Blog: Patient Insights & Thought Leadership

Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.

Case Study: Unlocking Unrivaled Programmatic Performance in Pharmaceutical Advertising

September 1, 2025

Unlock unrivaled reach and engagement in pharmaceutical advertising.

From Qualified to Converted: Why Your Next Campaign Needs to Focus on Low-Funnel Audiences

August 12, 2025

Is your health campaign focused on the right metric? Reaching a qualified patient is one thing, but reaching one who is ready to convert is everything. Here’s why the future is low-funnel.

The Pharma Paradox: Balancing Authenticity and Safety in Influencer Marketing

July 22, 2025

Authentic patient stories or compliant pharma campaigns? You don't have to choose. Here’s how to set a new standard for influence.

Why Health Union’s Audiences Make All the Difference in Influencer Marketing

July 9, 2025

Selecting the right patient is the first step of a successful influencer campaign. But how do we ensure that powerful, authentic content reaches the right audience?

The Role of Social Health in Treating Cancer as a Chronic Condition

February 27, 2023

Survey findings demonstrate the critical role of ongoing social health support for people living with – and beyond – cancer.

Understanding Rare Conditions: The Multifaceted Financial Impact

January 26, 2023

More than a third of Health Union’s Myasthenia Gravis In America 2022 survey respondents said their condition has negatively impacted their finances.

Bringing Patient Centricity to Life: Health Union’s Social Health Network

December 7, 2022

Health Union’s Social Health Network builds health leaders into confident and trustworthy partners for the healthcare industry. Here’s why that matters.

Patient and Caregiver Perspectives: How Pharma Can Improve the Chronic Condition Experience

November 30, 2022

Two health leaders share wins, challenges and opportunities they’ve faced as patient and caregiver to help pharma improve the chronic condition experience.

Healthcare Industry Thought Leadership

Contact